Company Metrics
LIXT Bitcoin Exposure
LIXT Valuation Metrics
LIXT Stock Returns
LIXT Trading & Risk
LIXT Options
About LIXTE Biotechnology's Bitcoin Treasury Strategy
LIXTE Biotechnology (LIXT) ranks #152 globally among Bitcoin treasury companies, with 10.5 Bitcoin in its corporate treasury worth approximately $811.66K at current prices. This represents 0.000% of the total 21 million Bitcoin that will ever exist.
Trading at a stock price of $3.35 per share with a market capitalization of $38.92M, LIXTE Biotechnology's stock currently trades at an mNAV (enterprise value to Bitcoin NAV multiple) of 42.93x. Bitcoin holdings represent 2% of the company's market cap, underscoring Bitcoin's central role in LIXTE Biotechnology's balance sheet strategy.
Recent stock performance shows +15.52% over the past week, +7.72% over the past month, -14.76% year-to-date, and +172.36% over the past year. LIXTE Biotechnology currently trades -46.49% from its 52-week high. The stock averages $134.05K in daily trading volume over the past 30 days, with 30-day volatility at 86.9%.